Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show

Pear Therapeutics to Participate in 9th Annual SVB Leerink Global Healthcare Conference


Pear Therapeutics, Inc., the leader in prescription digital therapeutics, today announced that Christopher D.T. Guiffre, J.D., M.B.A., Chief Financial Officer and Chief Operating Officer, will participate in the 9th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 26 at the Lotte New York Palace.

About Pear Therapeutics
Pear Therapeutics, Inc. is the leader in prescription digital therapeutics. We aim to redefine medicine by discovering, developing, and delivering clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurological conditions. Our lead product, reSET®, for the treatment of Substance Use Disorder, was the first prescription digital therapeutic to receive marketing authorization from the FDA to treat disease. Pear's second product, reSET-O®, for the treatment of Opioid Use Disorder, received marketing authorization from the FDA in December 2018. For more information, visit us at www.peartherapeutics.com.


These press releases may also interest you

at 01:55
Cellcom Israel Ltd. (the "Company") announced today that following the previously reported approval of the court to the sale of the controlling stake in Discount Investment Corporation Ltd. ? the Company's indirect controlling shareholder -  to a...

at 01:42
Kahoot!, the global learning platform company, today announced the acquisition of Drops, one of the fastest growing language platforms in the world. Through this acquisition, Kahoot! plans to further expand its platform and make language learning...

at 01:25
Mydecine Innovations Group Inc. (the "Company") announces that its previously issued financial statements for the fiscal year ended December 31, 2019, and the three- and six-month periods ended March 31, 2020 and June 30, 2020, any corresponding...

at 01:24
With their ability to transport electricity without loss and at zero resistance, superconductors are a technology that could solve a host of environmental and energy problems. The Nano Frontier Superconducting Materials Group at MANA, led by Prof....

at 01:15
Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing oncolytic viruses to target hard-to-treat solid tumors, today releases 18-month follow-up data from the randomized phase I/II trial of ONCOS-102 in combination with...

at 01:00
With online threats originating from across the world and on all levels of the internet only increasing, the need to remain dynamic and neutralize attacks before any damage can be done is paramount. The key to threat intelligence solutions is to...



News published on 12 february 2020 at 07:05 and distributed by: